Cardiff Oncology, Inc.·4

Jun 30, 9:38 AM ET

Mohindru Mani 4

4 · Cardiff Oncology, Inc. · Filed Jun 30, 2025

Insider Transaction Report

Form 4
Period: 2025-06-26
Mohindru Mani
DirectorInterim CEO
Transactions
  • Award

    Stock Options

    2025-06-26+40,565168,766 total
    Exercise: $3.16From: 2026-06-26Exp: 2035-06-26Common Stock (40,565 underlying)

Documents

1 file
  • 4
    ownership.xmlPrimary